The anxiolytic effects of flesinoxan, a 5-HT 1A receptor agonist, are not related to its neuroendocrine effects

By Groenink L.   Van der Gugten J.   Verdouw P.M.   Maes R.A.A.   Olivier B.  

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 185-193

Elsevier

Access to resources Recommend Favorite

Potential anxiolytic properties of R-(+)-8-OSO 2 CF 3 -PAT, a 5-HT 1A receptor agonist

By Barf T.   Korte S.M.   Korte-Bouws G.   Sonesson C.   Damsma G.   Bohus B.   Wikstrom H.  

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 205-211

Elsevier

Access to resources Recommend Favorite

Site-directed mutagenesis of the 5-HT 1B receptor increases the affinity of 5-HT for the agonist low-affinity conformation and reduces the intrinsic activity of 5-HT

By Granas C.   Nordquist J.   Mohell N.   Larhammar D.  

European Journal of Pharmacology, Vol. 421, Iss. 2, 2001-06 ,pp. : 69-76

Elsevier

Access to resources Recommend Favorite

SB-236057, a selective 5-HT 1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor

By Middlemiss D.N.   Gothert M.   Schlicker E.   Scott C.M.   Selkirk J.V.   Watson J.   Gaster L.M.   Wyman P.   Riley G.   Price G.W.  

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 359-365

Elsevier

Access to resources Recommend Favorite

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT 1B/1D receptor agonist

By Gupta P.   Butler P.   Shepperson N.B.   McHarg A.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 73-81

Elsevier

Access to resources Recommend Favorite